June 13, 2026 — New research shows that infrainguinal endovascular interventions for peripheral artery disease (PAD) ...
June 15, 2006 — Penumbra, Inc. has secured the CE Mark in Europe for Thunderbolt, further laying the groundwork for ...
June 12, 2026 — Medtronic plc recently announced it has completed its acquisition of Scientia Vascular, a privately-held ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 9 2026 — With the project “Triaging artificial intelligence (AI) Tool For Pulmonary Health Using Spectral X-ray ...
June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding ...
June 10, 2026 — New research shows that patients with peripheral artery disease (PAD) who adhere to pre-operative ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
June 10, 2026 — Siemens Healthineers has entered into a project agreement with the Advanced Research Projects Agency for ...
June 9, 2026.— Pentixapharm Holding AG has announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
June 8, 2026 – Embolization, Inc. will present its novel embolization coil, using proprietary shape-memory biocompatible ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
June 2, 2026 —HeartSciences Inc. has announced the commercial release of MyoVista Insights version 1.3, a major platform ...
May 11, 2026 — In May, Robocath announced the completion of patient enrollment in the FIH (First-In-Human) clinical ...
June 2, 2026 — Clarius Mobile Health has announced the availability of its new Ejection Fraction (EF) AI, which has been ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 3, 2026 — Medtronic has announced strategic investments in two privately held companies focused on the development ...
June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 15, 2026
